Universitätsklinikum Gießen und Marburg (UKGM)

Erratum: Correction: Crohn's Disease Exclusion Diet (CDED) and partial enteral nutrition (PEN) for remission induction in children and adolescents with Crohn's Disease - Updated statement from the CEDATA and Nutrition/Dietetics/Nutritional Medicine Working Groups of the Society for paediatric Gastroenterology and Nutrition (GPGE) (Zeitschrift fur Gastroenterologie (2026) 64 2 DOI: 10.1055/a-2699-7377.) Erratum: Crohnʼs Disease Exclusion Diet (CDED) und partielle enterale Ernährungstherapie (PEN) zur Remissionsinduktion bei Kindern und Jugendlichen mit Morbus Crohn – Aktualisierte Stellungnahme der Arbeitsgemeinschaften CEDATA und Ernährung/Diätetik/Ernährungsmedizin der Gesellschaft für pädiatrische Gastroenterologie und Ernährung (GPGE) (2026) Alexanidou E, Hörning A, de Laffolie J, Schmidt-Choudhury A, Däbritz J, Und Cedata-Studiengruppe AE Journal article, Erratum Crohn's Disease Exclusion Diet (CDED) and partial enteral nutrition (PEN) for remission induction in children and adolescents with Crohn's Disease-Updated statement from the CEDATA and Nutrition/Dietetics/Nutritional Medicine Working Groups of the Society for paediatric Gastroenterology and Nutrition (GPGE) Crohn's Disease Exclusion Diet (CDED) und partielle enterale Ernährungstherapie (PEN) zur Remissionsinduktion bei Kindern und Jugendlichen mit Morbus Crohn-Aktualisierte Stellungnahme der Arbeitsgemeinschaften CEDATA und Ernährung/Diätetik/Ernährungsmedizin der Gesellschaft für pädiatrische Gastroenterologie und Ernährung (GPGE) (2026) Alexanidou E, Hörning A, De Laffolie J, Schmidt-Choudhury A, Däbritz J, Und Cedata-Studiengruppe AE, Buderus S, et al. Journal article Surgical predictors of osteoradionecrosis in irradiated head and neck cancer patients: Jaw resection increases risk whereas neck dissection does not (2026) Hirsch J, Krause I, Tangmanee C, Vorwerk H, Stuck B, Poramate PA, Neff A Journal article Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy (2026) Dugas-Breit S, Forschner A, Erdmann M, Gutzmer R, Kähler KC, Holst I, Brekner A, et al. Journal article Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX). (2026) Burchert A, Nicolini FE, le Coutre P, Saussele S, Hochhaus A, Tuere E, Metzelder SK, et al. Journal article Mycophenolate mofetil versus prednisone for the initial treatment of idiopathic steroid-sensitive nephrotic syndrome in children in Germany (INTENT): a multicentre, open-label, randomised, controlled, parallel-group, non-inferiority, phase 3 trial (2026) Benz MR, Sander A, Ehren R, Höcker B, Fichtner A, Gellermann J, Thumfart J, et al. Journal article S3 guideline diagnostics and therapy of alopecia areata – Part 1: Diagnostics and epidemiology (2026) Blume-Peytavi U, Constantinou A, Tomova-Simitchieva T, Tanew A, Sticherling M, Girschick H, Vogt A, et al. Journal article Urine-based point-of-care detection of direct oral anticoagulant activity in acute stroke—accuracy at anti-Xa thresholds relevant for intravenous thrombolysis (2026) Gerner ST, Braemer A, Juenemann MB, Mrochen A, Braun T, Olbricht L, Diel NJ, et al. Journal article Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy (2026) Dendorfer SM, Schmidt-Brücken K, Kramer M, Steffen B, Schliemann C, Mikesch JH, Alakel N, et al. Journal article High pretreatment peripheral blood T-cell receptor clonality as a predictor of prolonged response in immune thrombocytopenia to the British Journal of Haematology (2026) Schmidt-Barbo P, Schultheiss C, Jauch AJ, Simnica D, Silling G, Hänel M, Chromik J, et al. Journal article